Patent: 10,233,245
✉ Email this page to a colleague
Summary for Patent: 10,233,245
Title: | Methods of treating inflammatory and autoimmune diseases with natalizumab |
Abstract: | Natalizumab is a safe and efficacious treatment for inflammatory and autoimmune diseases, such as multiple sclerosis, Crohn\'s Disease, and rheumatoid arthritis. Rare occurrences of progressive multifocal leucoencephalopathy during treatment suggest the possibility that it may be related to natalizumab treatment. Monitoring for JCV and informing caregivers and patients about the manifestations of progressive multifocal leucoencephalopathy can improve the safety of natalizumab therapy. |
Inventor(s): | Lieberburg; Ivan (Berkeley, CA) |
Assignee: | BIOGEN MA INC. (Cambridge, MA) |
Application Number: | 15/596,468 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,233,245 |
Patent Claims: | see list of patent claims |
Details for Patent 10,233,245
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Biogen Inc. | TYSABRI | natalizumab | Injection | 125104 | 11/23/2004 | ⤷ Try a Trial | 2026-02-28 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |